Journal of Hepatology
Volume 42, Issue 1 , Pages 68-74 , January 2005

Cardiac alterations in cirrhosis: reversibility after liver transplantation

  • Mireia Torregrosa

      Affiliations

    • Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, Passeig Vall d'Hebron 119, Barcelona 08035, Spain
    • ,
  • Santi Aguadé

      Affiliations

    • Nuclear Medicine Department, Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, Passeig Vall d'Hebron 119, Barcelona 08035, Spain
    • ,
  • Laura Dos

      Affiliations

    • Echocardiography Laboratory, Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, Passeig Vall d'Hebron 119, Barcelona 08035, Spain
    • ,
  • Rosa Segura

      Affiliations

    • Department of Biochemistry, Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, Passeig Vall d'Hebron 119, Barcelona 08035, Spain
    • ,
  • Antonio Gónzalez

      Affiliations

    • Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, Passeig Vall d'Hebron 119, Barcelona 08035, Spain
    • ,
  • Artur Evangelista

      Affiliations

    • Echocardiography Laboratory, Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, Passeig Vall d'Hebron 119, Barcelona 08035, Spain
    • ,
  • Joan Castell

      Affiliations

    • Nuclear Medicine Department, Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, Passeig Vall d'Hebron 119, Barcelona 08035, Spain
    • ,
  • Carlos Margarit

      Affiliations

    • Liver Transplantation Unit, Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, Passeig Vall d'Hebron 119, Barcelona 08035, Spain
    • ,
  • Rafael Esteban

      Affiliations

    • Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, Passeig Vall d'Hebron 119, Barcelona 08035, Spain
    • ,
  • Jaume Guardia

      Affiliations

    • Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, Passeig Vall d'Hebron 119, Barcelona 08035, Spain
    • ,
  • Joan Genescà

      Affiliations

    • Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Universitat Autónoma de Barcelona, Passeig Vall d'Hebron 119, Barcelona 08035, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34 932746140; fax: 34 932746068.

Received 2 June 2004 ,Revised 16 September 2004 ,Accepted 17 September 2004.

References 

  1. Bosch J, Pizcueta P, Feu F, Fernández M, García-Pagán JC. Pathophysiolgy of portal hypertension. Gastroenterol Clin North Am. 1992;21:1–14
  2. Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology. 1996;24:451–459
  3. Moller S, Henriksen JH. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart. 2002;87:9–15
  4. Myers RP, Lee SS. Cirrhotic cardiomyopathy and liver transplantation. Liver Transpl. 2000;6:S44–S52
  5. Evangelista A, Garcia-Dorado D, Garcia del Castillo H, Gonzalez-Alujas T, Soler-Soler J. Cardiac index quantification by Doppler ultrasound in patients without left ventricular outflow tract abnormalities. J Am Coll Cardiol. 1995;25:710–716
  6. Ortega-Alcalde D. Gated blood pool radionuclide ventriculography. In:  Candell-Riera J,  Ortega-Alcalde D editor. Nuclear cardiology in everyday practice. Dordrecht: Kluwer; 1994;p. 145–157
  7. Grose RD, Nolan J, Dillon JF, Errington M, Hannan WJ, Bouchier IAD, et al. Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. J Hepatol. 1995;22:326–332
  8. Wong F, Girgrah N, Graba J, Allidina Y, Liu P, Blendis L. The cardiac response to exercise in cirrhosis. Gut. 2001;49:268–275
  9. Valeriano V, Funaro S, Lionetti R, Riggio O, Pulcinelli G, Fiore P, et al. Modification of cardiac function in cirrhotic patients with and without ascites. Am J Gastroenterol. 2000;95:3200–3205
  10. Gould L, Shariff M, Zahir M, Di Lieto M. Cardiac hemodynamics in alcoholic patients with chronic liver disease and a presystolic gallop. J Clin Invest. 1969;48:860–868
  11. Kelbaek H, Eriksen J, Brynjolf I, Raboel A, Lund JO, Munck O, et al. Cardiac performance in patients with asymptomatic alcoholic cirrhosis of the liver. Am J Cardiol. 1984;54:852–855
  12. Laffi G, Barletta G, La Villa G, Del Bene R, Riccardi D, Ticali P, et al. Altered cardiovascular responsiveness to active tilting in non-alcoholic cirrhosis. Gastroenterology. 1997;113:891–898
  13. Van Obbergh L, Vallieres Y, Blaise G. Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related. J Hepatol. 1996;24:747–752
  14. Ma Z, Miyamoto A, Lee SS. Role of altered beta-adrenoreceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats. Gastroenterology. 1996;110:1191–1198
  15. Liu H, Ma Z, Lee SS. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Gastroenterology. 2000;118:937–944
  16. Lunseth JH, Olmstead EG, Forks G, Abboud F. A study of heart disease in one hundred eight hospitalized patients dying with portal cirrhosis. Arch Intern Med. 1958;102:405–413
  17. Hall EM, Olsen AY, Davis FE. Portal cirrhosis: clinical and pathological review of 782 cases from 16,600 necropsies. Am J Pathol. 1953;29:993–1027
  18. Pozzi M, Carugo S, Boari G, Pecci V, de Ceglia S, Maggliolini S, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients. Hepatology. 1997;26:1131–1137
  19. Inserte J, Perelló A, Agulló L, Ruiz-Meana M, Schlüter KD, Escalona N, et al. Left ventricular hypertrophy in rats with biliary cirrhosis. Hepatology. 2003;38:589–598
  20. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev. 2000;52:11–34
  21. Solis-Herruzo JA, Moreno D, Gonzales A, Larrodera L, Castellano G, Gutierrez J, et al. Effect of intrathoracic pressure on plasma arginine vasopressine levels. Gastroenterology. 1991;101:607–617
  22. Grossmann WE. Diastolic dysfunction and congestive heart failure. Circulation. 1990;81:1–7
  23. Navasa M, Feu F, Garcia Pagan J, Jimenez W, Llach J, Rimola A, et al. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology. 1993;17:355–360
  24. Piscaglia F, Zironi G, Gaiani S, Mazziotti A, Cavallari A, Gramantieri L, et al. Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-tem prospective study. Hepatology. 1999;30:58–64
  25. Sampathkumar P, Lerman A, Kim BY, Narr BJ, Poterucha JJ, Torsher LC, et al. Post-liver transplantation myocardial dysfunction. Liver Transpl Surg. 1998;4:399–403
  26. Therapondos G, Flapan AD, Dollinger MM, Garden OJ, Plevris JN, Hayes PC. Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: a prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus. Liver Transpl. 2002;8:690–700
  27. Pelliccia A. Athlete’s heart and hypertrophic cardiomyopathy. Curr Cardiol Rep. 2000;2:166–171
  28. Rajappan K, Bellenger NG, Melina G, Di Terlizzi M, Yacoub MH, Sheridan DJ, et al. Assessment of left ventricular mass regression after aortic valve replacement-cardiovascular magnetic resonance versus M-mode echocardiography. Eur J Cardiothorac Surg. 2003;24:59–65
  29. Zhang R, Crump J, Reisin E. Regression of left ventricular hypertrophy is a key goal of hypertension management. Curr Hypertens Rep. 2003;5:301–308
  30. Lee SS. Cardiac dysfunction in spontaneous bacterial peritonitis: a manifestation of cirrhotic cardiomyopathy. Hepatology. 2003;38:1089–1091
  31. Gines P, Guevara M, Perez-Villa F. Management of hepatorenal síndrome: another piece of the puzzle. Hepatology. 2004;40:16–18

PII: S0168-8278(04)00428-3

doi: 10.1016/j.jhep.2004.09.008

Journal of Hepatology
Volume 42, Issue 1 , Pages 68-74 , January 2005

Article Tools